"Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD) - A Prospective Pilot Observational Study"

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

August 1, 2027

Study Completion Date

September 1, 2027

Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
PROCEDURE

A blood sample for CA 19-9 (cancer detection test)

"* A blood sample for CA 19-9 (cancer detection test) levels will be taken at baseline.~* Contrast CT abdomen - Pancreas protocol will be done at baseline.~* EUS (Endoscopic Ultrasound) under moderate sedation will be done at baseline to you.~* If suspicious lesion is found on examination, Fine Needle Aspiration - FNA will be done."

All Listed Sponsors
lead

Asian Institute of Gastroenterology, India

OTHER

NCT06044064 - "Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD) - A Prospective Pilot Observational Study" | Biotech Hunter | Biotech Hunter